Which Indian company is to launch a new COVID-19 vaccine under the brand name Covovax?

Key Points

• The vaccine, named CovovaxTM, is produced by the Serum Institute of India under licence from Novavax and is part of the COVAX facility portfolio
• The World Health Organization issued an Emergency Use Authorization for the COVID-19 vaccine called Covovax.
• CovovaxTM was assessed under the WHO Emergency Use Listing (EUL) procedure based on the review of data on quality, safety and efficacy, a risk management plan, programmatic suitability, and manufacturing site inspections carried out by the Drugs Controller General of India.
• This step has given a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries.

​ Important Points

​